Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.22.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 687 $ 12,050
Operating expenses:    
Cost of product revenues 99 0
Research and development 5,735 6,948
Selling, general and administrative 14,591 6,696
Total operating expenses 20,425 13,644
Loss from operations (19,738) (1,594)
Other expense (income):    
Loss on extinguishment of debt 0 2,725
Amortization of debt issuance costs and discount 390 256
Interest income (13) (7)
Interest expense 1,059 214
Other income (13) 0
Warrant liabilities fair value adjustment (10,030) (1,296)
Derivative liabilities fair value adjustment (980) 90
Total other (income) expense (9,587) 1,982
Loss before taxes (10,151) (3,576)
Income tax (benefit) expense (4,700) 1,100
Net loss $ (5,451) $ (4,676)
Net loss per share attributable to common stockholders – basic    
Net loss per share – basic $ (0.17) $ (0.18)
Net loss per share attributable to common stockholders – diluted    
Net loss per share – diluted $ (0.18) $ (0.23)
Weighted average common shares outstanding – basic and diluted    
Basic 32,051,228 25,802,700
Diluted 33,189,428 26,523,920
Product Revenue, Net    
Revenue:    
Total revenue $ 687 $ 0
License Agreement Revenue    
Revenue:    
Total revenue $ 0 $ 12,050